Substrate overload: Glucose oxidation in human myotubes conquers palmitate oxidation through anaplerosis

Biochemical and Biophysical Research Communications

Volumn 391, Issue 3, 2010, Pages 1369-1373

  Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anaplerosis; Fuel selection; Glucose oxidation; Human; Lipid oxidation; Myotubes; Skeletal muscle

Indexed keywords

CITRIC ACID; GLUCOSE; PALMITIC ACID; PHENYLACETIC ACID; PYRUVATE CARBOXYLASE;

ADULT; ANAPLEROSIS; ARTICLE; CITRIC ACID CYCLE; CONCENTRATION (PARAMETERS); FATTY ACID OXIDATION; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLISM; METABOLITE; MYOTUBE; NORMAL HUMAN; PRIORITY JOURNAL; SOLUBILITY; VASTUS LATERALIS MUSCLE;

ACETATES; GLUCOSE; HUMANS; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OXIDATION-REDUCTION; PALMITATES;

EID: 73949146815     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.066     Document Type: Article

References (24)

1. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
2. Sidossis L.S., Stuart C.A., Shulman G.I., Lopaschuk G.D., and Wolfe R.R. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J. Clin. Invest 98 (1996) 2244-2250
3. Turcotte L.P., Swenberger J.R., and Yee A.J. High carbohydrate availability increases LCFA uptake and decreases LCFA oxidation in perfused muscle. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E177-E183
4. Sidossis L.S., and Wolfe R.R. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am. J. Physiol. 270 (1996) E733-E738
5. Gaster M. Metabolic flexibility is conserved in diabetic myotubes. J. Lipid Res. 48 (2007) 207-217
6. Gaster M., Kristensen S.R., Beck-Nielsen H., and Schroder H.D. A cellular model system of differentiated human myotubes. APMIS 109 (2001) 735-744
7. Gaster M., and Beck-Nielsen H. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects. Biochim. Biophys. Acta 1761 (2006) 100-110
8. Gaster M., Schroder H.D., Handberg A., and Beck-Nielsen H. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochim. Biophys. Acta 1537 (2001) 211-221
9. Gaster M., Beck-Nielsen H., and Schroder H.D. Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 109 (2001) 726-734
10. Farfari S., Schulz V., Corkey B., and Prentki M. Glucose-regulated anaplerosis and cataplerosis in pancreatic β-cells: possible implication of a pyruvate/citrate shuttle in insulin secretion. Diabetes 49 (2000) 718-726
11. Gaster M. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochem. Biophys. Res. Commun. 382 (2009) 766-770
12. Skrede S., Bremer J., Berge R.K., and Rustan A.C. Stimulation of fatty acid oxidation by a 3-thia fatty acid reduces triacylglycerol secretion in cultured rat hepatocytes. J. Lipid Res. 35 (1994) 1395-1404
13. Gaster M., and Beck-Nielsen H. The Reduced insulin mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin - evidence from cultured myotubes. Biochim. Biophys. Acta 1690 (2004) 85-91
14. Williamson J.R., and Corkey B.E. Assay of citric acid cycle intermediates and related compounds - update with tissue metabolite levels and intracellular distribution. Methods Enzymol. 55 (1979) 200-222
15. McGarry J.D., Mills S.E., Long C.S., and Foster D.W. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem. J. 214 (1983) 21-28
16. Winder W.W., Arogyasami J., Barton R.J., Elayan I.M., and Vehrs P.R. Muscle malonyl-CoA decreases during exercise. J. Appl. Physiol. 67 (1989) 2230-2233
17. Gaster M. The Dynamic of lipid oxidation in human myotubes. Biochim. Biophys. Acta 1791 (2009) 17-24
18. Liang X., Le W., Zhang D., and Schulz H. Impact of the intramitochondrial enzyme organization on fatty acid oxidation. Biochem. Soc. Trans. 29 (2001) 279-282
19. Gaster M. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?. Biochem. Biophys. Res. Commun. 387 (2009) 651-655
20. Jitrapakdee S., St M.M., Rayment I., Cleland W.W., Wallace J.C., and Attwood P.V. Structure, mechanism and regulation of pyruvate carboxylase. Biochem. J. 413 (2008) 369-387
21. Gaster M., Rustan A., and Beck-Nielsen H. Differential utilization of saturated palmitate and unsaturated oleate. Evidence from Cultured Myotubes. Diabetes 54 (2005) 648-656
22. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., Slezak L.A., Andersen D.K., Hundal R.S., Rothman D.L., Petersen K.F., and Shulman G.I. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest 103 (1999) 253-259
23. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., and Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
24. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., and Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236